NCT00640744View on ClinicalTrials.gov

Effect of Short Term Atorvastatin Treatment,80mg/Day on Early Regression of Carotid Artery Atherosclerotic Lesions

PHASE4UnknownINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

November 30, 2009

Study Completion Date

February 28, 2010

Conditions
Atherosclerosis
Interventions
DRUG

Atorvastatin

Atorvastatin 80 mg tablet/day for 3 months

Trial Locations (1)

77030

RECRUITING

Baylor College of Medicine, Houston

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Baylor College of Medicine

OTHER